Loading…
Silo Pharma, Inc. is projected to rise to $5.21 by 2027, a +21% move from its current price of $4.32. SILO is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $4.11 | $4.32 | $4.54 | +0.02% |
| Aug 6 | $4.03 | $4.32 | $4.64 | +0.04% |
| Aug 7 | $3.96 | $4.32 | $4.71 | +0.06% |
| Aug 8 | $3.91 | $4.32 | $4.78 | +0.07% |
| Aug 9 | $3.87 | $4.32 | $4.84 | +0.09% |
| Aug 10 | $3.83 | $4.32 | $4.89 | +0.11% |
| Aug 11 | $3.79 | $4.33 | $4.94 | +0.13% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.79 | $4.33 | $4.94 | +0.13% |
| Week 2 | $3.59 | $4.33 | $5.22 | +0.26% |
| Week 3 | $3.45 | $4.34 | $5.46 | +0.39% |
| Week 4 | $3.33 | $4.34 | $5.66 | +0.52% |
| Week 5 | $3.23 | $4.35 | $5.85 | +0.65% |
| Week 6 | $3.15 | $4.35 | $6.02 | +0.78% |
| Week 7 | $3.07 | $4.36 | $6.19 | +0.91% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company focused on therapeutics for underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It develops traditional therapies and psychedelic treatments in formulations.
The lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. The company is also developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief, and has two preclinical programs, SPC-14 for Alzheimer's disease and SPU-16 for multiple sclerosis. Collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore support its research.
It was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma was incorporated in 2010 and is based in Sarasota, Florida.
Silo Pharma, Inc. (SILO) trades in the Healthcare sector. The current price is $4.46 and the market capitalization is $5.03M, with a rank of 5187. These figures place the stock among smaller-cap healthcare names with focused development programs.
A major floor 92.3% below — a decisive break under it would weaken the trend.
The nearest floor, 3.0% below — buyers have tended to step in here.
The nearest ceiling, 78.9% above — a clean break opens room to run.
A major ceiling 106.3% above — clearing it would confirm fresh momentum.
Key SILO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SILO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.32 | Sell | $4.32 | Buy |
| MA 10 | $4.46 | Sell | $4.51 | Sell |
| MA 20 | $5.08 | Sell | $4.82 | Sell |
| MA 50 | $4.80 | Sell | $4.40 | Sell |
| MA 100 | $2.60 | Buy | $3.29 | Buy |
| MA 200 | $1.51 | Buy | $2.23 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.71 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -85.18 | Neutral |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.15 | Sell |
| ROC (12) | -14.05 | Sell |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | -0.35 | Sell |
| Awesome (5,34) | -1.20 | Sell |
| Ultimate (7,14,28) | 15.84 | Buy |
| Momentum (10) | -0.67 | Sell |
| Aroon Osc (25) | -64.00 | Sell |
| Hull MA (9) | 4.21 | Buy |
| ADX (14) | 24.18 | Sell |
| ATR (14) | 0.22 | Info |
Technically, the stock is currently bearish with an RSI of 40. The 50-day simple moving average stands at $5.86 and the 200-day simple moving average at $6.20, suggesting the price is trading below key longer-term averages. The immediate support level is $4.46 and the resistance is $7.73, with the stock’s 30-day price range ranging from $3.01 to $6.61.
Annualized volatility sits at 100%, indicating substantial upside and downside potential in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.19 | $4.32 | $5.71 | 0% | Neutral | |
| $3.84 | $5.21 | $7.62 | +21% | Bullish | |
| $3.09 | $4.44 | $6.91 | +3% | Neutral | |
| $2.57 | $3.87 | $6.31 | -11% | Neutral | |
| $2.81 | $4.43 | $7.51 | +2% | Neutral | |
| $2.53 | $4.15 | $7.28 | -4% | Neutral | |
| $3.08 | $5.25 | $9.48 | +21% | Bullish | |
| $3.60 | $6.36 | $11.80 | +47% | Bullish | |
| $3.26 | $5.98 | $11.36 | +38% | Bullish | |
| $3.22 | $6.10 | $11.86 | +41% | Bullish | |
| $3.86 | $8.58 | $18.28 | +99% | Bullish | |
| $4.62 | $10.27 | $23.62 | +138% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.19 | $4.32 | $5.04 | +0.00% |
| September 2026 | $3.47 | $4.20 | $5.30 | -2.75% |
| October 2026 | $3.58 | $4.39 | $5.65 | +4.58% |
| November 2026 | $3.46 | $4.30 | $5.61 | -2.24% |
| December 2026 | $3.45 | $4.32 | $5.71 | +0.47% |
Click any year to see its month-by-month SILO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, SILO is projected to trade between $4.19 and $5.71, averaging $4.32 — a potential gain of 0% from today's $4.32. Price action looks broadly range-bound.
Silo Pharma, Inc.'s 2027 outlook centres on $5.21, within a $3.84 to $7.62 range. That is up +21% on the projected 2026 average. That marks a +21% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, SILO could reach as high as $6.91, with a base case around $4.44 and support toward $3.09 — roughly +3% from $4.32. Price action looks broadly range-bound.
Expect SILO to range from $2.57 to $6.31 through 2029. The $3.87 average target implies a -11% move from current prices. That is -13% versus the projected 2028 average. A consolidation phase looks the most probable path here.
The SILO price prediction for 2030 points to an average of $4.43 (low $2.81, high $7.51) — a potential gain of +2% on today's $4.32. Price action looks broadly range-bound.
In 2031, SILO is projected to trade between $2.53 and $7.28, averaging $4.15 — a potential decline of -4% from today's $4.32. That is -6% versus the projected 2030 average. A consolidation phase looks the most probable path here.
Silo Pharma, Inc.'s 2032 outlook centres on $5.25, within a $3.08 to $9.48 range. That is up +26% on the projected 2031 average. That marks a +21% change versus current levels. Momentum favours further upside here.
By 2033, SILO could reach as high as $11.80, with a base case around $6.36 and support toward $3.60 — roughly +47% from $4.32. Buyers look set to stay in control over this stretch.
Expect SILO to range from $3.26 to $11.36 through 2034. The $5.98 average target implies a +38% move from current prices. That is -6% versus the projected 2033 average. Momentum favours further upside here.
The SILO price prediction for 2035 points to an average of $6.10 (low $3.22, high $11.86) — a potential gain of +41% on today's $4.32. Buyers look set to stay in control over this stretch.
In 2040, SILO is projected to trade between $3.86 and $18.28, averaging $8.58 — a potential gain of +99% from today's $4.32. That is up +41% on the projected 2035 average. Momentum favours further upside here.
Silo Pharma, Inc.'s 2050 outlook centres on $10.27, within a $4.62 to $23.62 range. That is up +20% on the projected 2040 average. That marks a +138% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in SILO today (≈ 231.481481 SILO) could be worth
$2,376.77
+$1,376.77 (+138%) by 2050 · US Dollar
Based on the average projected SILO price of $10.27 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SILOwould be worth at today's price.
$1,000 invested in SILO on Jul 31, 2025 (≈ 1,283.697073 SILO) would be worth
$5,545.57
+$4,545.57 (+454.6%) today · 5.55× · US Dollar
Based on a SILO entry price of $0.779 vs. today's $4.32.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.47 | $966.44 | -3.4% |
| 1 month ago | $6.17 | $700.16 | -30.0% |
| 3 months ago | $0.455 | $9,494.51 | +849.5% |
| 6 months ago | $0.327 | $13,211.01 | +1221.1% |
| 1 year ago | $0.779 | $5,545.57 | +454.6% |
| All time (5.0y) ago | $8.9 | $485.39 | -51.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SILO forecast.
Our base-case forecast reaches $8.60 around 2050.
Implied market cap at $8.60: $9.71M
The multi-year forecast shows a path of mixed near-term performance with more pronounced upside later. The 2026 forecast sits at a $4.46 average price with neutral sentiment. The 2027 forecast improves to an average of $5.38 with a 20.6% ROI and bullish sentiment, while 2032 shifts to a $5.76 average with a 29.1% ROI and bullish momentum.
2033 and 2034–2035 forecasts continue the bullish trend, with averages of $6.95, $6.22, and $6.53 and notable ROIs of 55.9%, 39.6%, and 46.3%, respectively. The long-run outlook strengthens meaningfully: by 2040 the average is $9.08 with a 103.5% ROI and bullish sentiment, and by 2050 the average is $11.40 with a 155.7% ROI and bullish sentiment. These figures indicate a potential for substantial upside over the coming decades, but years with lower averages and neutral or negative ROIs are also present, underscoring the uncertainty and the risk around timing and execution.
Tap a question to reveal the answer.
The 2030 forecast shows min $2.85, avg $4.60, max $7.98 with a 3.2% ROI and neutral sentiment.
Forecasts show a mixed path: 2027 avg $5.38 with 20.6% ROI and bullish sentiment, but years like 2028 and 2029 have lower averages (e.g., 2028 avg $4.38, 2029 avg $3.92) and negative ROIs in some cases, indicating uncertainty and no guaranteed gains.
Yes. The maximums include $10.66 in 2032, $13.23 in 2033, $19.91 in 2040, and $26.23 in 2050.
Current price is $4.46 and market cap is $5.03M.
The 30-day range is from a low of $3.01 to a high of $6.61.
Silo Pharma, Inc. Community Discussion
0Share your Silo Pharma, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.